Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.

2.

Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.

Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A.

J Hepatol. 2010 Mar;52(3):315-21. doi: 10.1016/j.jhep.2009.12.013. Epub 2009 Dec 24.

PMID:
20129690
3.

Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.

Sturm N, Thélu MA, Camous X, Dimitrov G, Ramzan M, Dufeu-Duchesne T, Bonorino P, Guillermet C, Brambilla E, Arvers P, Pernollet M, Leroy V, Zarski JP, Marche PN, Jouvin-Marche E.

J Hepatol. 2010 Jul;53(1):25-35. doi: 10.1016/j.jhep.2010.02.024. Epub 2010 Apr 20.

4.

Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.

Kang S, Xie J, Ma S, Liao W, Zhang J, Luo R.

Immunobiology. 2010;215(2):153-62. doi: 10.1016/j.imbio.2009.03.001. Epub 2009 May 17.

PMID:
19450895
5.

CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.

Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, Fujii H.

Int J Cancer. 2008 May 15;122(10):2286-93. doi: 10.1002/ijc.23392.

6.

Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.

Cordiglieri C, Marolda R, Franzi S, Cappelletti C, Giardina C, Motta T, Baggi F, Bernasconi P, Mantegazza R, Cavalcante P.

J Autoimmun. 2014 Aug;52:74-89. doi: 10.1016/j.jaut.2013.12.013. Epub 2014 Jan 4.

PMID:
24397961
7.

Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.

Itose I, Kanto T, Kakita N, Takebe S, Inoue M, Higashitani K, Miyazaki M, Miyatake H, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.

J Viral Hepat. 2009 Dec;16(12):844-52. doi: 10.1111/j.1365-2893.2009.01131.x. Epub 2009 May 26.

PMID:
19486278
8.
9.

Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis C.

Langhans B, Krämer B, Louis M, Nischalke HD, Hüneburg R, Staratschek-Jox A, Odenthal M, Manekeller S, Schepke M, Kalff J, Fischer HP, Schultze JL, Spengler U.

J Hepatol. 2013 Aug;59(2):229-35. doi: 10.1016/j.jhep.2013.04.011. Epub 2013 Apr 23.

PMID:
23624000
10.

Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus.

Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, Yoshie O.

J Virol. 2004 Feb;78(4):1665-74.

11.

Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.

Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW, Fleming KA, Banham AH, Klenerman P.

J Hepatol. 2007 Sep;47(3):316-24. Epub 2007 Apr 12.

PMID:
17475362
12.

Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.

Tapia B, Morel E, Martín-Díaz MA, Díaz R, Alves-Ferreira J, Rubio P, Padial A, Bellón T.

Clin Exp Allergy. 2007 May;37(5):704-13.

PMID:
17456218
13.

Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.

Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, Layland LE, Vidovic N, Hoerauf A, Oldenburg J, Sauerbruch T, Spengler U.

Clin Sci (Lond). 2010 Apr 20;119(2):97-109. doi: 10.1042/CS20090661.

PMID:
20222873
14.

The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection.

Palmer C, Corpuz T, Guirguis M, O'Toole S, Yan K, Bu Y, Jorgenson J, Talbot M, Loi K, Lloyd A, Zekry A.

Gut. 2010 Mar;59(3):397-404. doi: 10.1136/gut.2008.165316. Epub 2009 Mar 15.

PMID:
19289381
15.

Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans.

Cavassani KA, Campanelli AP, Moreira AP, Vancim JO, Vitali LH, Mamede RC, Martinez R, Silva JS.

J Immunol. 2006 Nov 1;177(9):5811-8.

16.

CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.

Maruyama T, Kono K, Izawa S, Mizukami Y, Kawaguchi Y, Mimura K, Watanabe M, Fujii H.

Dis Esophagus. 2010 Jul;23(5):422-9. doi: 10.1111/j.1442-2050.2009.01029.x. Epub 2009 Dec 11.

PMID:
20002703
17.

Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.

Claassen MA, de Knegt RJ, Janssen HL, Boonstra A.

J Virol. 2011 Jun;85(11):5323-30. doi: 10.1128/JVI.02551-10. Epub 2011 Mar 30.

18.

Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder.

Takegawa S, Jin Z, Nakayama T, Oyama T, Hieshima K, Nagakubo D, Shirakawa AK, Tsuzuki T, Nakamura S, Yoshie O.

Cancer Sci. 2008 Feb;99(2):296-302. doi: 10.1111/j.1349-7006.2007.00687.x.

19.

Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22.

Hammad H, Smits HH, Ratajczak C, Nithiananthan A, Wierenga EA, Stewart GA, Jacquet A, Tonnel AB, Pestel J.

Eur Cytokine Netw. 2003 Oct-Dec;14(4):219-28. Erratum in: Eur Cytokine Netw. 2004 Jan-Mar;15(1):73.

20.

Local accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata.

Cao Y, Zhao J, Lei Z, Shen S, Liu C, Li D, Liu J, Shen GX, Zhang GM, Feng ZH, Huang B.

J Immunol. 2008 Jun 1;180(11):7681-6.

Supplemental Content

Support Center